| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6342397
[patent_doc_number] => 20020034786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Tango-72 and Tango-77 nucleic acid molecules and polypeptides'
[patent_app_type] => new
[patent_app_number] => 09/862767
[patent_app_country] => US
[patent_app_date] => 2001-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13804
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034786.pdf
[firstpage_image] =>[orig_patent_app_number] => 09862767
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/862767 | Tango-72 and Tango-77 nucleic acid molecules and polypeptides | May 20, 2001 | Abandoned |
Array
(
[id] => 6358630
[patent_doc_number] => 20020058311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Chimeric leptin fused to immunoglobulin domain and use'
[patent_app_type] => new
[patent_app_number] => 09/859361
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5916
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058311.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859361
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859361 | Chimeric leptin fused to immunoglobulin domain and use | May 16, 2001 | Abandoned |
Array
(
[id] => 1284520
[patent_doc_number] => 06638741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-28
[patent_title] => 'Differentiation-suppressive polypeptide serrate-2'
[patent_app_type] => B2
[patent_app_number] => 09/855722
[patent_app_country] => US
[patent_app_date] => 2001-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21284
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/638/06638741.pdf
[firstpage_image] =>[orig_patent_app_number] => 09855722
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/855722 | Differentiation-suppressive polypeptide serrate-2 | May 15, 2001 | Issued |
| 09/831458 | Human cell surface receptor proteins | May 7, 2001 | Abandoned |
Array
(
[id] => 6158696
[patent_doc_number] => 20020147142
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Methods and reducing or maintaining reduced levels of blood lipids using OB protein compositions'
[patent_app_type] => new
[patent_app_number] => 09/850433
[patent_app_country] => US
[patent_app_date] => 2001-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9895
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 588
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20020147142.pdf
[firstpage_image] =>[orig_patent_app_number] => 09850433
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/850433 | Methods and reducing or maintaining reduced levels of blood lipids using OB protein compositions | May 6, 2001 | Abandoned |
| 09/848271 | Human tumor necrosis factor TR18 and met hods based thereon | May 3, 2001 | Abandoned |
Array
(
[id] => 1299097
[patent_doc_number] => 06623941
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-23
[patent_title] => 'Nucleic acids encoding human tumor necrosis factor TR20'
[patent_app_type] => B1
[patent_app_number] => 09/848295
[patent_app_country] => US
[patent_app_date] => 2001-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 104235
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/623/06623941.pdf
[firstpage_image] =>[orig_patent_app_number] => 09848295
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/848295 | Nucleic acids encoding human tumor necrosis factor TR20 | May 3, 2001 | Issued |
| 09/841751 | Cytokine family member EF-7 | Apr 24, 2001 | Abandoned |
Array
(
[id] => 5908528
[patent_doc_number] => 20020143147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Mammalian genes; related reagents'
[patent_app_type] => new
[patent_app_number] => 09/840795
[patent_app_country] => US
[patent_app_date] => 2001-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23191
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20020143147.pdf
[firstpage_image] =>[orig_patent_app_number] => 09840795
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/840795 | Mammalian genes; related reagents | Apr 22, 2001 | Abandoned |
Array
(
[id] => 6000628
[patent_doc_number] => 20020028798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Irrigation solution and method for inhibition of pain and inflammation'
[patent_app_type] => new
[patent_app_number] => 09/839633
[patent_app_country] => US
[patent_app_date] => 2001-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 40946
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028798.pdf
[firstpage_image] =>[orig_patent_app_number] => 09839633
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/839633 | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors | Apr 19, 2001 | Issued |
Array
(
[id] => 6131973
[patent_doc_number] => 20020077458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Death domain-containing receptor polynucleotides, polypeptides, and antibodies'
[patent_app_type] => new
[patent_app_number] => 09/835788
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 120366
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20020077458.pdf
[firstpage_image] =>[orig_patent_app_number] => 09835788
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/835788 | Death domain-containing receptor polynucleotides, polypeptides, and antibodies | Apr 16, 2001 | Abandoned |
Array
(
[id] => 6934250
[patent_doc_number] => 20010055594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'Use of certain drugs for treating nerve root injury'
[patent_app_type] => new
[patent_app_number] => 09/826893
[patent_app_country] => US
[patent_app_date] => 2001-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9820
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20010055594.pdf
[firstpage_image] =>[orig_patent_app_number] => 09826893
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/826893 | Use of certain drugs for treating nerve root injury | Apr 5, 2001 | Abandoned |
Array
(
[id] => 720528
[patent_doc_number] => 07049402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Tumor necrosis factor receptor-5'
[patent_app_type] => utility
[patent_app_number] => 09/826212
[patent_app_country] => US
[patent_app_date] => 2001-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 24
[patent_no_of_words] => 23776
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049402.pdf
[firstpage_image] =>[orig_patent_app_number] => 09826212
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/826212 | Tumor necrosis factor receptor-5 | Apr 4, 2001 | Issued |
Array
(
[id] => 1151392
[patent_doc_number] => 06770745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-03
[patent_title] => 'Common gamma chain blocking agents'
[patent_app_type] => B2
[patent_app_number] => 09/824286
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 31426
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 205
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770745.pdf
[firstpage_image] =>[orig_patent_app_number] => 09824286
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/824286 | Common gamma chain blocking agents | Apr 1, 2001 | Issued |
Array
(
[id] => 6536743
[patent_doc_number] => 20020137130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/814950
[patent_app_country] => US
[patent_app_date] => 2001-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 19968
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137130.pdf
[firstpage_image] =>[orig_patent_app_number] => 09814950
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/814950 | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof | Mar 22, 2001 | Abandoned |
| 09/787835 | Receptor based antagonists and methods of making and using | Mar 21, 2001 | Abandoned |
| 09/674235 | Human proteins having transmembrane domains and dnas encoding these proteins | Mar 18, 2001 | Abandoned |
Array
(
[id] => 5801499
[patent_doc_number] => 20020009775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Helical protein zalpha51'
[patent_app_type] => new
[patent_app_number] => 09/810052
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26973
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009775.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810052
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810052 | Helical protein zalpha51 | Mar 15, 2001 | Abandoned |
Array
(
[id] => 6377926
[patent_doc_number] => 20020119517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Leptin induced genes'
[patent_app_type] => new
[patent_app_number] => 09/804006
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28433
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119517.pdf
[firstpage_image] =>[orig_patent_app_number] => 09804006
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/804006 | Leptin induced genes | Mar 11, 2001 | Abandoned |
Array
(
[id] => 6889353
[patent_doc_number] => 20010024808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-09-27
[patent_title] => 'Leptin induced genes'
[patent_app_type] => new
[patent_app_number] => 09/804357
[patent_app_country] => US
[patent_app_date] => 2001-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28430
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20010024808.pdf
[firstpage_image] =>[orig_patent_app_number] => 09804357
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/804357 | Leptin induced genes | Mar 11, 2001 | Abandoned |
